HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Rodan + Fields Concealed Prostaglandin Risks From Lash Boost Users – Class Action

This article was originally published in The Rose Sheet

Executive Summary

Marketers of cosmetic lash enhancers that haven’t abandoned prostaglandin analogs in favor of peptides or botanical extracts should take heed of a proposed class action against Rodan + Fields in California’s Northern District. Plaintiffs say they would not have purchased the firm’s Lash Boost and suffered alleged adverse effects if they’d been properly informed about product risks.

You may also be interested in...



European Commission Examining Prostaglandins In Cosmetics: Are They Safe? Are They Drugs?

Marketers of cosmetic products that rely on prostaglandins or their analogues to grow eyelashes – or compete against companies that use the ingredients – have until 22 October to submit information to the Commission, which will help inform an assessment by the Scientific Committee on Consumer Safety.

Monat Offensive Fails To Deter Class Actions For Alleged Fraud, Hair Loss

Direct seller launched a preemptive strike last year against a professional stylist for her allegations that Monat hair products cause hair loss and other damage "just like WEN." In recent weeks, the firm has lodged more defamation suits against individuals, while plaintiffs have begun filing proposed class actions against Monat in Florida federal court

'FDA' Link In Rodan + Fields Prop 65 Warning Now Goes To The Agency

A link for FDA information included in Prop 65 warnings for Rodan & Fields benzophenone products went an industry site, the Environmental Working Group found. The firm replaced the link with one to FDA’s site, saying it used the industry website because it was more consumer friendly.

Related Content

Topics

UsernamePublicRestriction

Register

LL1134044

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel